SYGGF Company Profile and Key Details

Q: Who are the executives of SYGGF?

Dr. Gareth E. Walters Ph.D.Chief Regulatory OfficerMs. Brooke S ClarkeSenior Vice President & Head of CommunicationsMr. John WardChief Financial Officer & Executive DirectorProf. Donna DaviesCo-Founder & Member of Scientific Advisory BoardProf. Ratko DjukanovicCo-Founder & Member of Scientific Advisory BoardMs. Jody BrookesSenior Vice President & Head of Clinical OperationsMr. Richard HenningsChief Commercial OfficerMr. Richard MarsdenChief Executive Officer, MD & Executive DirectorProf. Stephen T. Holgate CBE, M.D.Co-Founder, Non-Executive Director & Member of Scientific Advisory BoardDr. Phillip David MonkChairman of Scientific Advisory Board, Chief Scientific Officer & Executive Director

PNK : SYGGF

Synairgen

$0.08

0.0091+13.76%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Synairgen plc (SYGGF) stock remained unchanged at $0.00 a share on OTC. The stock opened at $0.00, fluctuating between $0.00 to $0.01 during the session.

Stock Snapshot

0.0001

Prev. Close

110.27K

Market Cap

0.0001

Day Low

N/A

P/E Ratio

-0.10493

EPS (TTM)

-0.02

Cash Flow per Share

Open

1.1B

Number of Shares

0.0141

Day High

97.55%

Free Float in %

0.08

Book Value

10K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jan 07, 2026	0.00	0.00	0.00	0.00	500
Dec 24, 2025	0.00	0.00	0.00	0.00	25.76K
Dec 15, 2025	0.00	0.00	0.00	0.00	6K
Dec 04, 2025	0.00	0.00	0.00	0.00	2K
Nov 11, 2025	0.00	0.00	0.00	0.00	1K
Nov 05, 2025	0.00	0.00	0.00	0.00	5.69K
Sep 18, 2025	0.00	0.00	0.00	0.00	0
Sep 15, 2025	0.00	0.00	0.00	0.00	0
Sep 12, 2025	0.00	0.00	0.00	0.00	450
Sep 11, 2025	0.00	0.00	0.00	0.00	0
Sep 08, 2025	0.00	0.00	0.00	0.00	0
Sep 04, 2025	0.00	0.00	0.00	0.00	1K
Sep 02, 2025	0.00	0.00	0.00	0.00	10K
Aug 27, 2025	0.00	0.00	0.00	0.00	1.5K
Aug 26, 2025	0.00	0.00	0.00	0.00	0
Aug 22, 2025	0.00	0.00	0.00	0.00	10K
Aug 20, 2025	0.00	0.00	0.00	0.00	1K
Aug 15, 2025	0.00	0.00	0.00	0.00	0
Aug 12, 2025	0.00	0.00	0.00	0.00	0
Aug 11, 2025	0.00	0.00	0.00	0.00	0

Contact Details

Southampton, LO SO16 6YD

United Kingdom

https://www.synairgen.com 442 380 512800

About Company

Synairgen plc is a biopharmaceutical company focused on the discovery and advancement of therapeutic drugs for various respiratory conditions. Their product pipeline features SNG001, an inhaled interferon beta under development for the treatment of COVID-19. They are also conducting Phase II clinical trials for an inhaled formulation of interferon beta (IFN-ß), targeting both asthma exacerbated by the common cold and flu, and the treatment or prevention of chronic obstructive pulmonary disease (COPD). Furthermore, Synairgen is developing a LOXL2 inhibitor specifically for idiopathic pulmonary fibrosis (IPF) disease. This LOXL2 inhibitor is being developed through a licensing and collaborative agreement with Pharmaxis Ltd. The company was founded in 2004 and is based in Southampton, United Kingdom.

Stock Peers

LZAGF

-5-0.92%

Lonza Group AG$541.00 GNMSF

Genmab A/S$268.61 CMXHF

CSL Limited$192.00 CSLLY

0.75+0.79%

CSL Limited$95.35 UCBJY

-0.06-0.08%

UCB SA$73.15 LZAGY

-0.33-0.61%

Lonza Group AG$53.87 PHMMF

4.3+16.01%

Pharma Mar, S.A.$31.15 BVNKF

Bavarian Nordic A/S$21.20 GRTX

1.53+9.80%

Galera Therapeutics, Inc.$17.15 NURPF

Neuren Pharmaceuticals Limited$14.00

Frequently Asked Questions

What is the current Synairgen plc (SYGGF) stock price?

Synairgen plc (OTC: SYGGF) stock price is $0.00 in the last trading session. During the trading session, SYGGF stock reached the peak price of $0.01 while $0.00 was the lowest point it dropped to. The percentage change in SYGGF stock occurred in the recent session was 0% while the dollar amount for the price change in SYGGF stock was $0.00.

SYGGF's industry and sector of operation?

The OTC listed SYGGF is part of Biotechnology industry that operates in the broader Healthcare sector. Synairgen plc designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SYGGF?

Dr. Gareth E. Walters Ph.D.
Chief Regulatory Officer
Ms. Brooke S Clarke
Senior Vice President & Head of Communications
Mr. John Ward
Chief Financial Officer & Executive Director
Prof. Donna Davies
Co-Founder & Member of Scientific Advisory Board
Prof. Ratko Djukanovic
Co-Founder & Member of Scientific Advisory Board
Ms. Jody Brookes
Senior Vice President & Head of Clinical Operations
Mr. Richard Hennings
Chief Commercial Officer
Mr. Richard Marsden
Chief Executive Officer, MD & Executive Director
Prof. Stephen T. Holgate CBE, M.D.
Co-Founder, Non-Executive Director & Member of Scientific Advisory Board
Dr. Phillip David Monk
Chairman of Scientific Advisory Board, Chief Scientific Officer & Executive Director

How SYGGF did perform over past 52-week?

SYGGF's closing price is 66.84% higher than its 52-week low of $0.00 where as its distance from 52-week high of $0.01 is -48.22%.

How many employees does SYGGF have?

Number of SYGGF employees currently stands at 34.

Link for SYGGF official website?

Official Website of SYGGF is: https://www.synairgen.com

How do I contact SYGGF?

SYGGF could be contacted at phone 442 380 512800 and can also be accessed through its website. SYGGF operates from Mailpoint 810, Southampton, LO SO16 6YD, United Kingdom.

How many shares of SYGGF are traded daily?

SYGGF stock volume for the day was 10K shares. The average number of SYGGF shares traded daily for last 3 months was 9.22K.

What is the market cap of SYGGF currently?

The market value of SYGGF currently stands at $110.27K with its latest stock price at $0.00 and 1.1B of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	34
Beta	7.15
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	34
Beta	7.15
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

SYGGF Company Profile and Key Details

Synairgen

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Valuation Metrics

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Valuation Metrics